new guidelines on using low-molecular-weight heparins (Lovenox, Fragmin, Innohep)

The American Heart Assoc just released new guidelines on using low-molecular-weight heparins (Lovenox, Fragmin, Innohep).

The bottom line...LMW heparins are now considered FIRST-LINE for prevention and treatment of venous thromboembolism (VTE).

Lovenox (enoxaparin) and Fragmin (dalteparin) can also be used as an alternative to heparin for unstable angina.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 200+ CE courses, including the popular CE-in-the-Letter
  • Helpful, in-depth Technician Tutorials
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get a quote